The APE1 redox inhibitor E3330 has been suggested as a potential treatment for neoplasms, as it can inhibit the growth and migration of pancreatic tumor cells (63) and also exerts inhibitory effects in other cancer types (13). This evidence concerns the gene APEX1 and cancer.